Current stock page

Catalysts

ALHC Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Sep 4, 2026

ALHC

Catalysts
Alignment Healthcare, Inc.
Healthcare· Medical - Healthcare Plans
AIQ Score
NeutralAIQ Edge 2/10
Low Priority
Relative Laggard
Score data as of Sep 4, 2026
Last price
$13.54
-$0.01 (-0.04%)
Latest market quote
Momentum44
Value42
Quality37
Risk Resilience51
Sentiment53
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 29, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 42/100

Momentum 44/100 and sentiment 53/100 before the next covered event.

Recent coverage
5 articles

Updated Sep 5, 2026 · Sentiment 1.90%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 44/100AIQ Edge 2/10 Relative Laggard
Beat rate
88%
7 of 8 reported periods
Average surprise
+133.5%
Across covered historical reports
Latest result
+31.8%
Jul 30, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Jul 30, 2026$0.13$0.17+31.8%$1.31B$1.34B
Apr 30, 2026$0.01$0.05+400.0%$1.22B$1.24B
Feb 26, 2026-$0.15-$0.05+66.7%$1B$1.01B
Oct 30, 2025-$0.01$0.02+300.0%$980.9M$993.7M
Jul 30, 2025-$0.07$0.07+200.0%$959.95M$1.02B
May 1, 2025-$0.12-$0.05+58.3%$888.26M$926.93M
Feb 27, 2025-$0.18-$0.16+11.1%$677.42M$701.24M
Oct 29, 2024-$0.14-$0.14+0.0%$675.47M$692.43M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
13
Buy
2
Hold
12-month analyst target
$19.60
+44.76% versus current price
Based on 3 analyst observations. Targets are estimates, not predictions.
Low target
$16.00
+18.17% vs latest price
Average target
$19.60
+44.76% vs latest price
High target
$22.00
+62.48% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 29, 2026

Next known earnings or reporting date.

EPS estimate-$0.02

Current analyst expectation for the upcoming report.

Revenue estimate$1.31B

Current analyst expectation for the upcoming report.

Sentiment score53

News pressure around the setup.

Momentum score44

Where event reaction would show up first.

AIQ score42/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
3
Average target
$19.60
Target upside
44.76%
Target range
$16.00 - $22.00
90-day revisions
6

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
2
Negative
2
markets.businessinsider.com · Sep 1, 2026

Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (ALHC) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

New York, New York--(Newsfile Corp. - July 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Al...

financialpost.com · Aug 17, 2026

Kaplan Fox Advises Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation into Potential Securities Law Violations

NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) —

financialpost.com · Aug 14, 2026

Kaplan Fox Notifies Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation into Potential Securities Law Violations

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) —

financialpost.com · Aug 12, 2026

Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm About a Potential Securities Claim

NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) —

seekingalpha.com · Aug 11, 2026

Alignment Healthcare: The Drawdown I Told You To Wait For Has Arrived (NASDAQ:ALHC)

Alignment Healthcare (ALHC) upgraded to Buy after a 38% drawdown; Q2 beat, guidance raised and 40%+ upside.

Open full news and sentiment

ALHC Catalysts FAQ

What are the next catalysts for ALHC stock?

ALHC's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ALHC stock?

Upcoming events that could move ALHC include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ALHC's next earnings report affect the stock?

ALHC's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ALHC stock higher?

ALHC could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ALHC stock?

ALHC could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.